GMAB logo

Genmab A/S (GMAB) EBIT

annual EBIT:

$1.35B+$524.67M(+63.80%)
December 31, 2024

Summary

  • As of today (May 22, 2025), GMAB annual earnings before interest & taxes is $1.35 billion, with the most recent change of +$524.67 million (+63.80%) on December 31, 2024.
  • During the last 3 years, GMAB annual EBIT has risen by +$721.50 million (+115.35%).
  • GMAB annual EBIT is now at all-time high.

Performance

GMAB EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

quarterly EBIT:

$35.11M-$487.29M(-93.28%)
March 1, 2025

Summary

  • As of today (May 22, 2025), GMAB quarterly earnings before interest & taxes is $35.11 million, with the most recent change of -$487.29 million (-93.28%) on March 1, 2025.
  • Over the past year, GMAB quarterly EBIT has dropped by -$1.75 million (-4.74%).
  • GMAB quarterly EBIT is now -94.76% below its all-time high of $670.32 million, reached on June 30, 2020.

Performance

GMAB quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

TTM EBIT:

$1.12B-$1.75M(-0.16%)
March 1, 2025

Summary

  • As of today (May 22, 2025), GMAB TTM earnings before interest & taxes is $1.12 billion, with the most recent change of -$1.75 million (-0.16%) on March 1, 2025.
  • Over the past year, GMAB TTM EBIT has increased by +$295.57 million (+35.71%).
  • GMAB TTM EBIT is now -8.78% below its all-time high of $1.23 billion, reached on September 30, 2020.

Performance

GMAB TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GMAB EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.8%-4.7%+35.7%
3 y3 years+115.3%-62.2%+101.9%
5 y5 years+213.4%-33.2%+137.2%

GMAB EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+115.3%-93.3%at low-0.2%+101.9%
5 y5-yearat high+213.4%-94.8%at low-8.8%+137.2%
alltimeall timeat high+1247.2%-94.8%+208.8%-8.8%+1772.4%

GMAB EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$35.11M(-93.3%)
$1.12B(-0.2%)
Dec 2024
$1.35B(+63.8%)
$522.40M(+104.1%)
$1.12B(+49.8%)
Sep 2024
-
$255.98M(-17.4%)
$750.96M(-15.3%)
Jun 2024
-
$309.76M(+740.6%)
$886.20M(+7.1%)
Mar 2024
-
$36.85M(-75.2%)
$827.68M(-0.3%)
Dec 2023
$822.34M(-16.7%)
$148.36M(-62.1%)
$830.05M(+8.7%)
Sep 2023
-
$391.22M(+55.7%)
$763.48M(-6.4%)
Jun 2023
-
$251.24M(+540.5%)
$816.05M(-11.5%)
Mar 2023
-
$39.23M(-52.0%)
$921.99M(-5.5%)
Dec 2022
$987.51M(+57.9%)
$81.79M(-81.6%)
$975.69M(-5.5%)
Sep 2022
-
$443.79M(+24.2%)
$1.03B(+33.2%)
Jun 2022
-
$357.18M(+284.4%)
$775.44M(+39.4%)
Mar 2022
-
$92.92M(-33.2%)
$556.33M(-19.9%)
Dec 2021
$625.50M(-31.0%)
$139.05M(-25.4%)
$694.73M(+7.8%)
Sep 2021
-
$186.28M(+34.9%)
$644.43M(-4.8%)
Jun 2021
-
$138.08M(-40.3%)
$676.66M(-44.0%)
Mar 2021
-
$231.33M(+160.7%)
$1.21B(+17.4%)
Dec 2020
$906.15M(+110.9%)
$88.74M(-59.4%)
$1.03B(-16.3%)
Sep 2020
-
$218.52M(-67.4%)
$1.23B(+10.1%)
Jun 2020
-
$670.32M(+1175.4%)
$1.12B(+136.1%)
Mar 2020
-
$52.56M(-81.9%)
$473.57M(+8.7%)
Dec 2019
$429.74M(+68.3%)
$289.97M(+175.3%)
$435.62M(+63.5%)
Sep 2019
-
$105.32M(+309.4%)
$266.46M(+38.5%)
Jun 2019
-
$25.73M(+76.1%)
$192.36M(+2.2%)
Mar 2019
-
$14.61M(-87.9%)
$188.27M(-12.8%)
Dec 2018
$255.35M(+57.4%)
$120.80M(+287.0%)
$215.84M(+8.1%)
Sep 2018
-
$31.22M(+44.3%)
$199.66M(+12.4%)
Jun 2018
-
$21.64M(-48.7%)
$177.66M(-24.5%)
Mar 2018
-
$42.18M(-59.7%)
$235.34M(+20.0%)
Dec 2017
$162.26M(-3.4%)
$104.63M(+1035.6%)
$196.10M(-4.5%)
Sep 2017
-
$9.21M(-88.4%)
$205.25M(-8.4%)
Jun 2017
-
$79.31M(+2587.9%)
$224.05M(+34.8%)
Mar 2017
-
$2.95M(-97.4%)
$166.26M(+0.3%)
Dec 2016
$168.02M
$113.77M(+306.1%)
$165.72M(+49.3%)
Sep 2016
-
$28.02M(+30.2%)
$111.00M(+6.5%)
Jun 2016
-
$21.52M(+791.0%)
$104.23M(+17.7%)
DateAnnualQuarterlyTTM
Mar 2016
-
$2.42M(-95.9%)
$88.54M(-21.2%)
Dec 2015
$112.72M(+109.7%)
$59.04M(+177.9%)
$112.32M(+75.1%)
Sep 2015
-
$21.25M(+264.1%)
$64.13M(-5.2%)
Jun 2015
-
$5.84M(-77.7%)
$67.65M(+20.8%)
Mar 2015
-
$26.19M(+141.4%)
$55.99M(+15.9%)
Dec 2014
$53.76M(+339.3%)
$10.85M(-56.2%)
$48.30M(+1.4%)
Sep 2014
-
$24.77M(-525.2%)
$47.66M(+100.9%)
Jun 2014
-
-$5.83M(-131.5%)
$23.72M(-10.2%)
Mar 2014
-
$18.50M(+81.3%)
$26.41M(+99.7%)
Dec 2013
$12.24M(-163.6%)
$10.20M(+1121.9%)
$13.23M(>+9900.0%)
Sep 2013
-
$835.10K(-126.7%)
$114.50K(-102.2%)
Jun 2013
-
-$3.13M(-158.9%)
-$5.30M(-38.6%)
Mar 2013
-
$5.32M(-282.9%)
-$8.62M(-64.3%)
Dec 2012
-$19.23M(-50.5%)
-$2.91M(-36.5%)
-$24.15M(-4.8%)
Sep 2012
-
-$4.58M(-29.1%)
-$25.35M(-20.2%)
Jun 2012
-
-$6.45M(-36.8%)
-$31.76M(-16.3%)
Mar 2012
-
-$10.21M(+148.2%)
-$37.94M(-2.9%)
Dec 2011
-$38.82M(+163.3%)
-$4.11M(-62.6%)
-$39.05M(+6.5%)
Sep 2011
-
-$10.98M(-13.0%)
-$36.65M(-1221.2%)
Jun 2011
-
-$12.63M(+11.5%)
$3.27M(-2644.1%)
Mar 2011
-
-$11.33M(+560.0%)
-$128.50K(-99.2%)
Dec 2010
-$14.74M(-51.0%)
-$1.72M(-105.9%)
-$16.04M(-163.1%)
Sep 2010
-
$28.94M(-280.6%)
$25.43M(-179.5%)
Jun 2010
-
-$16.03M(-41.2%)
-$31.99M(-33.7%)
Mar 2010
-
-$27.24M(-168.5%)
-$48.23M(+75.9%)
Dec 2009
-$30.11M(-74.4%)
$39.75M(-239.6%)
-$27.41M(-59.2%)
Sep 2009
-
-$28.48M(-11.7%)
-$67.17M(+73.6%)
Jun 2009
-
-$32.27M(+402.2%)
-$38.69M(+502.2%)
Mar 2009
-
-$6.42M
-$6.42M
Dec 2008
-$117.41M(+92.3%)
-
-
Dec 2007
-$61.05M(-17.1%)
-
-
Dec 2006
-$73.63M(+12.4%)
-
-
Dec 2005
-$65.51M(-181.0%)
-
-
Dec 2004
$80.92M(+29.4%)
-
-
Dec 2003
$62.55M(-15.2%)
-
-
Dec 2002
$73.73M
-
-

FAQ

  • What is Genmab A/S annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Genmab A/S?
  • What is Genmab A/S annual EBIT year-on-year change?
  • What is Genmab A/S quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Genmab A/S?
  • What is Genmab A/S quarterly EBIT year-on-year change?
  • What is Genmab A/S TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Genmab A/S?
  • What is Genmab A/S TTM EBIT year-on-year change?

What is Genmab A/S annual earnings before interest & taxes?

The current annual EBIT of GMAB is $1.35B

What is the all time high annual EBIT for Genmab A/S?

Genmab A/S all-time high annual earnings before interest & taxes is $1.35B

What is Genmab A/S annual EBIT year-on-year change?

Over the past year, GMAB annual earnings before interest & taxes has changed by +$524.67M (+63.80%)

What is Genmab A/S quarterly earnings before interest & taxes?

The current quarterly EBIT of GMAB is $35.11M

What is the all time high quarterly EBIT for Genmab A/S?

Genmab A/S all-time high quarterly earnings before interest & taxes is $670.32M

What is Genmab A/S quarterly EBIT year-on-year change?

Over the past year, GMAB quarterly earnings before interest & taxes has changed by -$1.75M (-4.74%)

What is Genmab A/S TTM earnings before interest & taxes?

The current TTM EBIT of GMAB is $1.12B

What is the all time high TTM EBIT for Genmab A/S?

Genmab A/S all-time high TTM earnings before interest & taxes is $1.23B

What is Genmab A/S TTM EBIT year-on-year change?

Over the past year, GMAB TTM earnings before interest & taxes has changed by +$295.57M (+35.71%)
On this page